Platelets and hemostasis: a new perspective on an old subject

Slides:



Advertisements
Similar presentations
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
Advertisements

Uncontrolled Wnt signaling causes leukemia
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice by Sravya Kattula, James R. Byrnes,
by Matt W. Goschnick, Lai-Man Lau, Janet L. Wee, Yong S. Liu, P
Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease by Alec A. Schmaier,
Tissue-Specific Expression of Functional Platelet Factor XI Is Independent of Plasma Factor XI Expression by Chang-jun Hu, Frank A. Baglia, David C.B.
Polyphosphates rock! A role in thrombosis?
Defective release of α granule and lysosome contents from platelets in mouse Hermansky-Pudlak syndrome models by Ronghua Meng, Jie Wu, Dawn C. Harper,
Finding a diamond in the (mouse is) rough
Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel by Andy S.
Vessel wall BAMBI contributes to hemostasis and thrombus stability
Masahiro Ueda, Tatsuo Shibata  Biophysical Journal 
Information Integration and Communication in Plant Growth Regulation
Inherited CalDAG-GEFI deficiency
by Lisa A. Porter, I. Howard Cukier, and Jonathan M. Lee
T regulatory cells turn on T regulatory cells
Fusion genes in cord blood
Activity flow of the mTOR signaling network.
Fluorescent neutrophils throw the spotlight on inflammation
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk by Alisa S. Wolberg, Dougald.
Alterations in platelet secretion differentially affect thrombosis and hemostasis by Smita Joshi, Meenakshi Banerjee, Jinchao Zhang, Akhil Kesaraju, Irina.
Thrombin generation: biochemical possibilities and clinical reality
Rap1-GTP–interacting adaptor molecule (RIAM) is dispensable for platelet integrin activation and function in mice by Simon Stritt, Karen Wolf, Viola Lorenz,
The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies by.
Coordination of platelet agonist signaling during the hemostatic response in vivo by Jian Shen, Sara Sampietro, Jie Wu, Juan Tang, Shuchi Gupta, Chelsea.
Platelets can enhance vascular permeability
Gremlin: vexing VEGF receptor agonist
Ex Vivo Cultured Megakaryocytes Express Functional Glycoprotein IIb-IIIa Receptors and Are Capable of Adenovirus-Mediated Transgene Expression by Nauder.
A new red cell shape helps the clot
Diverging signaling events control the pathway of GPVI down-regulation in vivo by Tamer Rabie, David Varga-Szabo, Markus Bender, Rastislav Pozgaj, Francois.
RGS10 shapes the hemostatic response to injury through its differential effects on intracellular signaling by platelet agonists by Peisong Ma, Shuchi Gupta,
Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice by Kellie R. Machlus, Jessica C. Cardenas, Frank C.
Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis by Manasa K. Nayak, Nirav Dhanesha,
SNARE-dependent membrane fusion initiates α-granule matrix decondensation in mouse platelets by Irina D. Pokrovskaya, Smita Joshi, Michael Tobin, Rohan.
Protein kinase C signaling dysfunction in von Willebrand disease (p
Enhancing functional platelet release in vivo from in vitro–grown megakaryocytes using small molecule inhibitors by Danuta Jarocha, Karen K. Vo, Randolph.
Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network by Timothy J. Stalker, Elizabeth A. Traxler,
A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant by Shauna L. French, Claudia Thalmann, Paul F.
by Silvia Mele, Stephen Devereux, Andrea G
by Alex J. Cornish, Phuc H. Hoang, Sara E. Dobbins, Philip J
Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.
Crosstalk Complexities between Auxin, Cytokinin, and Ethylene in Arabidopsis Root Development: From Experiments to Systems Modeling, and Back Again  Junli.
by Kalpana Parvathaneni, and David W. Scott
by Cheryl L. Maier, Amanda Mener, Seema R. Patel, Ryan P
The Ribosome Emerges from a Black Box
Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice by Xuemei Fan, Conghui Wang, Panlai Shi, Wen Gao, Jianmin Gu, Yan.
Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib by Alexander P. Bye, Amanda J. Unsworth,
MicroRNAs in a Cardiac Loop: Progenitor or Myocyte?
Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice by Hui Zhou, Meihong Deng, Yingjie Liu, Chenxuan.
by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc
Florian Huber, Josef Käs, Björn Stuhrmann  Biophysical Journal 
by Christine L. Kempton, and Amanda B. Payne
A population-based longitudinal study on the implication of demographic changes on blood donation and transfusion demand by Andreas Greinacher, Kerstin.
Ontogeny of platelet function
Activity flow of PDGFR signaling pathways.
Aggregation tracings of platelets lacking PLCβ2/β3.
Actin assembly in response to thrombin.
Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies by Nadine Müller-Calleja, Svenja.
by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther
Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor by Gauthami Jalagadugula, Lawrence.
Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura by Liang Zheng, Yingying.
A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2 by Shadi Khalil, Maja Holy, Stephen Grado, Robert.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Sickle cells and sickle trait in thrombosis
The flux of glucose from the blood to the membrane to muscle.
Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action by Shiva Keshava, Jagan Sundaram,
Fig. 1. Generic metabolic pathway and its corresponding adjacency matrices. The graph of a static network (A) is ... Fig. 1. Generic metabolic pathway.
A binding relationship with thrombin
Mutations in the zebrafish hmgcs1 gene reveal a novel function for isoprenoids during red blood cell development by Jose A. Hernandez, Victoria L. Castro,
A schematic diagram showing the mechanism by which L5 triggers platelet activation and aggregation. A schematic diagram showing the mechanism by which.
Presentation transcript:

Platelets and hemostasis: a new perspective on an old subject by Lawrence F. Brass, Scott L. Diamond, and Timothy J. Stalker BloodAdv Volume 1(1):5-9 November 29, 2016 © 2016 by The American Society of Hematology

A systems view of the hemostatic response to penetrating injuries. A systems view of the hemostatic response to penetrating injuries. High-resolution confocal fluorescence microscopy studies performed in mice show that the hemostatic structure has a characteristic architecture whose properties emerge as platelets accumulate, altering local conditions. (A) Presence of a core of highly activated, densely packed platelets overlaid with a shell of loosely packed, less activated platelets and the transition zone that exists between them. (B) Manner in which soluble platelet agonists such as thrombin, ADP, and TxA2 form concentration gradients radiating from the site of injury. (C) Distribution of the agonists is determined in part by differences in transport rates in the narrowing gaps between platelets, gaps whose dimensions decrease as clot retraction proceeds. Lawrence F. Brass et al. Blood Adv 2016;1:5-9 © 2016 by The American Society of Hematology

Integrating the platelet signaling network to obtain an optimal response. Integrating the platelet signaling network to obtain an optimal response. Although platelet signaling pathways were originally described one at a time, they form a closely regulated network that both promotes and limits the hemostatic response. The figure focuses on events downstream of the G protein–coupled receptors for thrombin, ADP, and TxA2. It illustrates 2 GTP-dependent switching points or nodes in the network, crosstalk between pathways, and the presence of regulatory loops that affect information flow through the nodes. The green and red boxes summarize transgenic mouse models associated with gain or loss of function, respectively. References are in the text. Lawrence F. Brass et al. Blood Adv 2016;1:5-9 © 2016 by The American Society of Hematology